The Significance of Cervical Lymph Nodes in Well-Differentiated Thyroid Cancer

  • Richard W. Nason
  • K. Alok Pathak
Part of the Head and Neck Cancer Clinics book series (HNCC)


Well-differentiated thyroid cancer (WDTC), papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC) are relatively rare. In 2012, a total of 5,600 new cases of thyroid cancer were diagnosed in Canada. Death from thyroid cancer is an even rarer event, with <400 recorded deaths in the same year [1]. To put this in perspective, breast cancer accounted for 22,900 new cases and 5,200 deaths. WDTC has a good prognosis with minimal morbidity if treated properly. Adequate initial surgery offers the most useful contribution to both overall and relapse survival for WDTC. The extent of this surgery has generated controversy for decades and this controversy includes the indications and extent of surgery for cervical lymph nodes. The challenge in the management of this malignancy is to tailor the treatment to be aggressive enough to eradicate the disease, but not so excessive as to cause unnecessary morbidity.


Thyroid Cancer Sentinel Lymph Node Biopsy Neck Dissection Papillary Thyroid Cancer Central Compartment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Canadian Cancer Society. Canada cancer statistics 2012.
  2. 2.
    Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418–28.Google Scholar
  3. 3.
    Cady B, Sedgwick CE, Meissner A, et al. Risk factor analysis in differentiated thyroid cancer. Cancer. 1979;43:810–20.PubMedCrossRefGoogle Scholar
  4. 4.
    Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer. 1985;55:794–804.PubMedCrossRefGoogle Scholar
  5. 5.
    Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well-differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992;75:714–20.PubMedGoogle Scholar
  6. 6.
    McConahey WM, Hay ID, Woolner LB, et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc. 1986;61:978–96.PubMedCrossRefGoogle Scholar
  7. 7.
    Frazell EL, Foote Jr FW. Papillary thyroid carcinoma: pathological findings in cases with and without clinical evidence of cervical node involvement. Cancer. 1955;8:1164–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Tennvall J, Björklund A, Moller T, et al. Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up. Cancer. 1986;57:1405–14.PubMedCrossRefGoogle Scholar
  9. 9.
    Carcangiu ML, Zampi G, Pupi A, et al. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer. 1985;55:805–28.PubMedCrossRefGoogle Scholar
  10. 10.
    Hutter RV, Frazell EL, Foote Jr FW. Elective radical neck dissection: an assessment of its use in the management of papillary thyroid cancer. CA Cancer J Clin. 1970;20:87–93.PubMedCrossRefGoogle Scholar
  11. 11.
    Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med. 1981;70:511–8.PubMedCrossRefGoogle Scholar
  12. 12.
    McHenry CR, Rosen IB, Walfish PG. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg. 1991;162:353–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Sanders LE, Rossi RL. Occult well differentiated thyroid carcinoma presenting as cervical node disease. World J Surg. 1995;19:642–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Cady B, Sedgwick CE, Meissner WA, et al. Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg. 1976;184:541–53.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Attie JN, Khafif RA, Steckler RM. Elective neck dissection in papillary carcinoma of the thyroid. Am J Surg. 1971;122:464–71.PubMedCrossRefGoogle Scholar
  16. 16.
    Noguchi S, Noguchi A, Murakami N. Papillary carcinoma of the thyroid I. Developing pattern of metastasis. Cancer. 1970;26:1053–60.PubMedCrossRefGoogle Scholar
  17. 17.
    Harness J, Thompson N, McCleod M, et al. Follicular carcinoma of the thyroid. Trends and treatment. Surgery. 1984;96:972–80.PubMedGoogle Scholar
  18. 18.
    Frankenthaler RA, Sellin RV, Cangir A, et al. Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients. Am J Surg. 1990;160:341–3.PubMedCrossRefGoogle Scholar
  19. 19.
    Stack B, Ferris R, Goldenberg D. American thyroid association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid. 2012;22:501–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Machens A, Hinze R, Thomusch O, et al. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg. 2002;26:22–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Scheumann GFW, Gimm O, Wegener G, et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg. 1994;18:559–67; discussion 567–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Yanir Y, Doweck I. Regional metastases in well-differentiated thyroid carcinoma: pattern of spread. Laryngoscope. 2008;118:433–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas. Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237:399–407.PubMedCentralPubMedGoogle Scholar
  24. 24.
    Kupferman M, Weinstock Y, Santillan A. Predictors of level V metastases in well differentiated thyroid cancer. Head Neck. 2008;30:1469–74.PubMedCrossRefGoogle Scholar
  25. 25.
    Dionigi G, Dionigi R, Bartalena L, et al. Surgery of lymph nodes in papillary thyroid cancer. Expert Rev Anticancer Ther. 2006;6:1217–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Quabain S, Nakano S, Baba M, et al. Distribution of lymph node metastases in pN0 well-differentiated thyroid carcinoma. Surgery. 2002;131:249–56.CrossRefGoogle Scholar
  27. 27.
    Gimm O, Rath FW, Dralle H. Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg. 1998;85:252–4.PubMedCrossRefGoogle Scholar
  28. 28.
    Ardito G, Revelli L, Tosti F, et al. Surgery of differentiated thyroid carcinoma, lymph node metastases and locoregional recurrence. Rays. 2000;25:199–206.PubMedGoogle Scholar
  29. 29.
    Noguchi S, Murakami N. The value of lymph-node dissection in patients with differentiated thyroid cancer. Surg Clin North Am. 1987;67:251–61.PubMedGoogle Scholar
  30. 30.
    Ozaki O, Ito K, Kobayashi K, et al. Modified neck dissection for patients with nonadvanced, differentiated carcinoma of the thyroid. World J Surg. 1988;12:825–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Coburn M, Wanebo HJ. Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg. 1992;164:671–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Marcheta FC, Sako K, Matsuura H. Modified neck dissection for carcinoma of the thyroid gland. Am J Surg. 1970;120:452–5.CrossRefGoogle Scholar
  33. 33.
    Sivanandan R, Soo KC. Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid. Br J Surg. 2001;88:1241–4.PubMedCrossRefGoogle Scholar
  34. 34.
    Ferlito A, Robbins KT, Shah JP, et al. Proposal for a rational classification of neck dissections. Head Neck. 2011;33:445–50.PubMedGoogle Scholar
  35. 35.
    Kupferman ME, Patterson M, Mandel SJ, et al. Patterns of lateral neck metastasis in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:857–60.PubMedCrossRefGoogle Scholar
  36. 36.
    Pingpank Jr JF, Sasson AR, Hanlon AL, et al. Tumor above the spinal accessory nerve in papillary thyroid cancer that involves lateral neck nodes. Arch Otolaryngol Head Neck Surg. 2002;128:1275–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Pasieka JL. Sentinel lymph node biopsy in the management of thyroid disease. Br J Surg. 2001;88:321–2.PubMedCrossRefGoogle Scholar
  38. 38.
    Yüce I, Cağh S, Bayram A. Regional metastatic pattern of papillary thyroid carcinoma. Eur Arch Otorhinolaryngol. 2010;267:437–41.PubMedCrossRefGoogle Scholar
  39. 39.
    Spriano G, Ruscito P, Pellini R, et al. Pattern of regional metastases and prognostic factors in differentiated thyroid carcinoma. Acta Otorhinolaryngol Ital. 2009;29:312–6.PubMedCentralPubMedGoogle Scholar
  40. 40.
    Roh J, Kim J, Park C. Central cervical nodal metastases from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis. Ann Surg Oncol. 2008;15:2482–6.PubMedCrossRefGoogle Scholar
  41. 41.
    Ahmadi N, Grewal A, Davidson BJ. Patterns of cervical lymph node metastases in primary and recurrent papillary thyroid cancer. J Oncol. 2011;2011:735678.PubMedCentralPubMedCrossRefGoogle Scholar
  42. 42.
    Farrag T, Fin F, Brownlee N, et al. Is routine dissection of level II-b and V-a necessary in patients with papillary thyroid cancer undergoing lateral neck dissection for FNA-confirmed metastases in other levels. World J Surg. 2009;33:1680–3.PubMedCrossRefGoogle Scholar
  43. 43.
    Fee BJ, Wang SG, Lee JC, et al. Level IIb lymph node metastasis in neck dissection for papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2007;133:1028–30.CrossRefGoogle Scholar
  44. 44.
    Watkinson JC, Franklyn JA, Olliff JF. Detection and surgical treatment of cervical lymph nodes in differentiated thyroid cancer. Thyroid. 2006;16:187–94.PubMedCrossRefGoogle Scholar
  45. 45.
    Ali S, Tiwari R, Snow GB. False-positive and false-negative neck nodes. Head Neck Surg. 1985;8:78–82.PubMedCrossRefGoogle Scholar
  46. 46.
    American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214.CrossRefGoogle Scholar
  47. 47.
    Ito Y, Amino N, Miyauchi A. Thyroid ultrasongraphy. World J Surg. 2010;34:1171–80.PubMedCrossRefGoogle Scholar
  48. 48.
    Liao S, Shindo M. Management of well differentiated thyroid cancer. Otolaryngol Clin North Am. 2012;45:1163–79.PubMedCrossRefGoogle Scholar
  49. 49.
    Muller M, Knoefrel W, Gilbertt J, et al. Fateral cervical node metastases in papillary thyrois cancer: a systematic review of imaging-guided and prophylactic removal of the lateral compartment. Clin Endocrinol. 2012;77:126–31.CrossRefGoogle Scholar
  50. 50.
    Choi J, Kim J, Kwak J, et al. Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT. AJR Am J Roentgenol. 2009;193:871–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Wanebo HJ, Andrews W, Kaiser DF. Thyroid cancer: some basic considerations. Am J Surg. 1981;142:474–9.PubMedCrossRefGoogle Scholar
  52. 52.
    Hay ID, Bergstralh EJ, Grant CS, et al. Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989. Surgery. 1999;126:1173–81; discussion 1181–2.Google Scholar
  53. 53.
    Byar DP, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer. 1979;15:1033–41.PubMedCrossRefGoogle Scholar
  54. 54.
    Hay ID, Grant CS, Taylor WF, et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery. 1987;102:1088–95.PubMedGoogle Scholar
  55. 55.
    Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947–53.PubMedGoogle Scholar
  56. 56.
    Hay I, Bergstralh E, Goellner J, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114:105–7; discussion 1057–8.Google Scholar
  57. 57.
    DeGroot LJ, Kaplan EL, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71:414–24.PubMedCrossRefGoogle Scholar
  58. 58.
    Shah JP, Loree TR, Dharker D, et al. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg. 1992;164:658–61.PubMedCrossRefGoogle Scholar
  59. 59.
    Rossi RL, Cady B, Silverman MF, et al. Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg. 1986;10:612–22.PubMedCrossRefGoogle Scholar
  60. 60.
    Tisell LE, Nilsson B, Mölne J, et al. Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg. 1996;20:854–9.PubMedCrossRefGoogle Scholar
  61. 61.
    Sellers M, Beenken S, Blankenship A, et al. Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am J Surg. 1992;164:578–81.PubMedCrossRefGoogle Scholar
  62. 62.
    Hughes CJ, Shaha AR, Shah JP, et al. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck. 1996;18:127–32.PubMedCrossRefGoogle Scholar
  63. 63.
    Lundgren CI, Hall P, Dickman PW, et al. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case–control study. Cancer. 2006;106:524–31.Google Scholar
  64. 64.
    Shaha AR, Shah JP, Loree TR. Patterns of failure in differentiated carcinoma of the thyroid based on risk groups. Head Neck. 1998;20:26–30.PubMedCrossRefGoogle Scholar
  65. 65.
    Harwood J, Clark OH, Dunphy JE. Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg. 1978;136:107–12.PubMedCrossRefGoogle Scholar
  66. 66.
    Sugatini I, Yanagisawa A, Shimizu A, et al. Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy. World J Surg. 1998;22:731–7.CrossRefGoogle Scholar
  67. 67.
    Kitajiri S, Hiraumi H, Hirose T, et al. The presence of large lymph nodes metastasis as a prognostic factor of papillary thyroid carcinoma. Auris Nasus Larynx. 2003;30:169–74.PubMedCrossRefGoogle Scholar
  68. 68.
    Ito Y, Fukushima M, Tomada C, et al. Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastases to the lateral compartment. Endocr J. 2009;56:759–76.PubMedCrossRefGoogle Scholar
  69. 69.
    Simpson WJ, McKinney SE, Carruthers JS, et al. Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients. Am J Med. 1987;83:479–88.PubMedCrossRefGoogle Scholar
  70. 70.
    Leboulleux S, Rubino C, Baudin E, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab. 2005;10:5723–9.CrossRefGoogle Scholar
  71. 71.
    Beasley NJP, Lee J, Eski S, et al. Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg. 2002;128:825–8.PubMedCrossRefGoogle Scholar
  72. 72.
    Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid. 2012;22:1144–52.PubMedCrossRefGoogle Scholar
  73. 73.
    Ito Y, Higashiyama T, Takamura Y, et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastases: validity of prophylactic modified radical neck dissection. World J Surg. 2007;31:2085–91.PubMedCrossRefGoogle Scholar
  74. 74.
    Ricarte-Filho J, Ganly I, Rivera M, et al. Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension. Thyroid. 2012;22:575–84.PubMedCrossRefGoogle Scholar
  75. 75.
    Sobin L, Gospodarowicz M, Wittekind C, editors. TNM classification of malignant tumors, Union for International Cancer Control. 7th ed. New York: Wiley-Blackwell; 2010.Google Scholar
  76. 76.
    Lim Y, Choi E, Yoon Y. Occult lymph nodes in neck level V in papillary thyroid carcinoma. Surgery. 2010;147:241–5.PubMedCrossRefGoogle Scholar
  77. 77.
    Nam IC, Park JO, Joo YH, et al. Pattern and predictive factors of regional lymph node metastasis in papillary thyroid carcinoma: a prospective study. Head Neck. 2013;35:40–5.PubMedCrossRefGoogle Scholar

Copyright information

© K. Alok Pathak, Richard W. Nason, Janice L. Pasieka, Rehan Kazi, Raghav C. Dwivedi 2015

Authors and Affiliations

  1. 1.Head and Neck Surgical OncologyCancerCare ManitobaWinnipegCanada
  2. 2.Head and Neck Surgical OncologyCancerCare Manitoba, University of ManitobaWinnipegCanada

Personalised recommendations